Tabletby Cipla Ltd
In Treatment of HIV infection Tafmune EM 200mg/25mg Tablet prevents HIV from multiplying in the body. It helps control the infection and makes the immune system work better. This lowers the chances of complications, such as new infections, and improves the qua…
Tafmune EM 200mg/25mg Tablet is a combination of antiretroviral medicines that are prescribed to treat HIV (human immunodeficiency virus) infection. It boosts the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome). Tafmune EM 200mg/25mg Tablet restricts the growth of HIV in the body and reduces the risk of getting HIV-related complications to improve the lifespan of an individual. The medicine can be taken with or without food and taking it regularly at the same time each day increases its effectiveness. A dose of this medicine should not be missed as doing so can affect your recovery. It is important to complete the full course of the treatment until your doctor advises you to stop. Sudden discontinuation of the treatment may affect the potency of the medicine.The most common side effects of this medicine are nausea and diarrhea. They generally resolve after some time but if they persist or become serious, inform your doctor. This medicine can also make you feel lazy or weak, therefore, it is advised to avoid driving. Drinking plenty of fluid can help you cope with the side effects, hence stay hydrated.Before starting the treatment with Tafmune EM 200mg/25mg Tablet, consult your doctor if you are pregnant, breastfeeding, or have any health condition. They may suggest regular blood tests to check your blood counts, kidney and liver functions, and other health conditions.
Tafmune EM 200mg/25mg Tablet is a combination of two medicines, emtricitabine and tenofovir alafenamide. They belong to a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs). Emtricitabine interrupts the virus life cycle by inhibiting a crucial enzyme called HIV-1 reverse transcriptase. Tenofovir alafenamide is converted to tenofovir diphosphate which gets incorporated into viral DNA, resulting in the inhibition of HIV replication.
Habit Forming :: No|Therapeutic Class :: ANTI INFECTIVES
Consult a certified doctor for personalised medical advice.